Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

CAIRE DIAGNOSTICS FenomPro REF 900-0001 SN ***** - Product Usage: a portable Recalled by CAIRE DIAGNOSTICS INC Due to Erroneously high FeNO levels which may contribute to...

Date: February 26, 2021
Company: CAIRE DIAGNOSTICS INC
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact CAIRE DIAGNOSTICS INC directly.

Affected Products

CAIRE DIAGNOSTICS FenomPro REF 900-0001 SN ***** - Product Usage: a portable, non-invasive device to measure fractional exhaled nitric oxide (FeNO) in human breath. Fenom Pro should not be used in critical care, emergency care or in anesthesiology.

Quantity: 381 units (171 units U.S. and 210 units O.U.S.)

Why Was This Recalled?

Erroneously high FeNO levels which may contribute to premature discontinuation of effective asthma treatment and persistent underlying disease. Two issues affecting the FeNO readings: 1) Drift in the calibration gases and 2) Software error. Each of these issues can cause FeNO scores/results to be erroneously high.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About CAIRE DIAGNOSTICS INC

CAIRE DIAGNOSTICS INC has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report